Profilo
Lisa Sinclair is Senior Vice President-Corporate Operations at Arvinas, Inc. since 2022.
Formerly, Ms. Sinclair was VP-Global R&D Portfolio & Performance at AstraZeneca, Inc., Head-Programs & Alliance Management at Springworks Therapeutics, Inc., and Head-Corporate & Commercial Strategy at Rallybio Corp.
Education includes undergraduate studies at the University of Vermont.
Posizioni attive di Lisa Sinclair
| Società | Posizione | Inizio |
|---|---|---|
| ARVINAS, INC. | Direttore operativo | 15/08/2022 |
Precedenti posizioni note di Lisa Sinclair
| Società | Posizione | Fine |
|---|---|---|
| SPRINGWORKS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Corporate Officer/Principal | - |
| RALLYBIO CORPORATION | Corporate Officer/Principal | - |
Formazione di Lisa Sinclair
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
University of Vermont
University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Health Technology |
Arvinas, Inc.
Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
Springworks Therapeutics, Inc.
Springworks Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes medicines for nervous system disorders | Health Technology |
Rallybio Corp.
Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
















